Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Ascentage Pharma presented results from five preclinical studies at AACR 2025, showcasing innovative drug candidates targeting hematological malignancies and solid tumors.
Ascentage Pharma's APG-2449, a FAK/ALK/ROS1 inhibitor, has been cleared by China's CDE to enter two Phase III registrational studies for NSCLC.